Search

Search Constraints

You searched for: Author/Creator Allory, Yves

Search Results

1. A prospective descriptive 1‐year study in France of all BCG therapy dispensations for non‐muscle‐invasive bladder cancer. (14th December 2022)

3. An essential role for decorin in bladder cancer invasiveness. Issue 12 (20th October 2013)

5. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group. (November 2017)

6. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group. (September 2017)

7. Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer. Issue 9 (13th January 2015)

8. Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer. Issue 9 (13th January 2015)

9. Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer. Issue 16 (29th June 2021)

10. Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes. (February 2020)